William J. McBride
Neuroscience · Indiana University
Publications
669
Citations
27,788
Est. group size
—
Recurring co-author estimate
Active years
60
Publishing since 1967
William J. McBride's neuroscience research centers on how brain chemicals influence behavior related to alcohol use, using rat models to study the neural circuits and neurotransmitter systems (such as glutamate and serotonin) involved in alcohol drinking, reward, and craving. The work examines specific brain regions like the nucleus accumbens and prefrontal cortex to understand the mechanisms underlying alcohol reinforcement. The record also includes work touching on antibody-based and radiopharmaceutical therapies in cancer contexts.
Publication activity was steady in the late 2010s, spiked sharply in 2023, and has been low in the most recent years, giving an uneven overall pattern.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
No award with a current end date on record.
11 earlier awards
- NIH R01AA022287Jul 2013 – May 2018 · $312k awarded
Neuronal underpinnings of repeated deprivations on cue-induced alcohol-seeking
- NIH R01AA012262Apr 2000 – Jan 2018 · $347k awarded
CNS sites for the Rewarding Actions of Alcohol
- NIH T32AA007462Sep 1985 – May 2016 · $392k awarded
Training Grant on Genetic Aspects of Alcoholism
- NIH RC2AA019366Sep 2009 – Aug 2012 · $1.2M awarded
Ethanol and nicotine co-abuse: cross sensitization of their reinforcing actions
- NIH R01AA010721Aug 1995 – May 2012 · $327k awarded
Neurobiology of high alcohol-seeking behavior
- NIH U01AA016652Sep 2006 – Aug 2011 · $136k awarded
Excessive alcohol drinking and CNS regional changes in genes expression
- NIH R01AA010256Dec 1994 – Feb 2011 · $323k awarded
Neurobiological Factors in Adolescent Alcohol Drinking
- NIH R01AA014437Jan 2005 – Dec 2010 · $251k awarded
Involvement of Aldehydes in Alcohol Addiction
- NIH R01AA011261Aug 1997 – Mar 2007 · $346k awarded
Neural Basis of the Alcohol Deprivation Effect
- NIH P41RR018942Sep 2005 – Aug 2006 · $48k awarded
BIOCHEMICAL BASIS OF ALCOHOL DEPENDENCY
- NIH P60AA007611 · $315k awarded
ANIMAL GENETICS
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~8 · 6% small-team papers (≤3 authors) · across 35 venues
- Glutamate transmission in the prelimbic cortex and nucleus accumbens shell is involved in ethanol reinforcement and drinking in rats
Frontiers in Behavioral Neuroscience · 2026
- N12 Patient perspectives of switch in route of administration among patients established on long term intravenous Infliximab therapy
Journal of Crohn s and Colitis · 2025
- Inhibitory and excitatory conditioned cues associated with alcohol differentially modulate the nucleus accumbens shell: involvement of 5-HT7 receptors
Frontiers in Psychiatry · 2025
- N11 Switching from intravenous to subcutaneous infliximab enhances trough levels and can facilitate de-escalation of concomitant immunomodulation, irrespective of the HLA DQA1*05 status: a prospective real-world study
Journal of Crohn s and Colitis · 2025
- P309 Impact of EBV Status on decision making for advanced therapies in IBD Patients
Journal of Crohn s and Colitis · 2024
- Data from Improved Therapeutic Results by Pretargeted Radioimmunotherapy of Non–Hodgkin's Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody
2023
- Data from Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2–SN-38 Antibody Conjugate (Sacituzumab Govitecan)
2023
- Data from Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2–SN-38 Antibody Conjugate (Sacituzumab Govitecan)
2023
- Supplementary Figure S4 from Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2–SN-38 Antibody Conjugate (Sacituzumab Govitecan)
2023
- Data from A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma
2023
- Data from CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
2023
- Data from CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
2023
- Inhibitory and excitatory alcohol-seeking cues distinct roles in behavior, neurochemistry, and mesolimbic pathway in alcohol preferring (P) rats
Drug and Alcohol Dependence · 2023
- Data from Improved Therapeutic Results by Pretargeted Radioimmunotherapy of Non–Hodgkin's Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody
2023
- Supplementary Figure 1 from A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma
2023
- PMC×6
- Alcoholism Clinical and Experimental Research×5
- PLoS neglected tropical diseases×4
- PLoS ONE×3
- Psychopharmacology×3
- Janet Best
Neuroscience · The Ohio State University
- Maria Waselus
Neuroscience · University of Michigan
- F. Woodward Hopf
Neuroscience · Indiana University
- Eric A. Engleman
Neuroscience · Indiana University
- M. S. Reid
Neuroscience · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile